Compare KELYA & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KELYA | LAB |
|---|---|---|
| Founded | 1946 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 438.6M | 449.9M |
| IPO Year | N/A | 2011 |
| Metric | KELYA | LAB |
|---|---|---|
| Price | $8.83 | $1.62 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $16.00 | $1.35 |
| AVG Volume (30 Days) | 557.0K | ★ 2.1M |
| Earning Date | 11-06-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,392,800,000.00 | $169,737,000.00 |
| Revenue This Year | $0.72 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.46 | ★ 79.77 |
| 52 Week Low | $7.98 | $0.92 |
| 52 Week High | $15.11 | $2.25 |
| Indicator | KELYA | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 41.67 | 70.94 |
| Support Level | $8.88 | $1.46 |
| Resistance Level | $9.28 | $1.51 |
| Average True Range (ATR) | 0.25 | 0.07 |
| MACD | 0.14 | 0.02 |
| Stochastic Oscillator | 46.86 | 84.48 |
Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.